Article
Cancer-associated mutations in protein kinase C theta are loss-of-function.
The Biochemical journal - 19 Jun 2024
Hodapp Stefanie J, Gravel Nathan, Kannan Natarajan, Newton Alexandra C
Abstract excerpt
The Ca2+-independent, but diacylglycerol-regulated, novel protein kinase C (PKC) theta (θ) is highly expressed in hematopoietic cells where it participates in immune signaling and platelet function. Mounting evidence suggests that PKCθ may be involved in cancer, particularly blood cancers, breast cancer, and gastrointestinal stromal tumors, yet how to target this kinase (as an oncogene or as a tumor suppressor)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
